Backed by 5AM Ventures.
About the role
This individual will lead in the day-to-day operations, planning, set-up, execution, and closeout of assigned clinical trials. They will oversee the planning and management of the operational aspects, including CRO and vendor oversight, to achieve project milestones and clinical study timelines in alignment with company goals and in compliance with local, ICH, GCP, and company policies and procedures. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- BA/BS degree with 7 + years of combined experience supporting and independently managing clinical trial activities
- Strong knowledge of ICH/GCP and regulatory requirements, with a strong preference for experience with EU-CTR
- Strong experience in the drug development process, including trial design, trial planning and management, and CRO and vendor oversight
- Excellent verbal and written communication skills
- Proven ability to work effectively across functions
More about this role
What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1).
2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex...
Browse similar: Startup jobs · Boston